NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

- He mentioned that they can’t just call these scientists and doctors and ask them to rush or give updates/timelines because their investors would like to know. This makes me think the authoring of the paper is complete and it is in review/approval stages. Now I’m not terribly familiar with medical journal publication processes, so I’m not sure if this would imply these revisions/iterations are being done pre or post submittal.

so NWBO taking its time to get peer-reviewing done, not rushing these "scientists and doctors" to get the updates and timelines. According to DI these scientists and doctors do not need to be rushed for the investors that would like to know... How about patients would they not like to know?

According to Vubru

Someone will always be slow to take care of these requirements, and with 60+ co-authors, I can see this taking up to a couple of weeks between submission and actually being sent out for review. So my guess is that they by today would have gotten to the point of having an article submitted. As I have said in prior posts, if their original planned PFS and OS outcomes (DCVAX vs. the internal placebo group) are not significant and the only significant findings are the comparisons to historical controls, getting this accepted by NEJM or Lancet may be challenging. However, I assume they would want to try one or both of these top journals first. These high end journals do an internal editorial board review of submissions before the paper is sent out for peer-review.

If they are now in peer-reviewing then normally it would take a couple of weeks but the phase they are in I would say 2 months out still for the scientific publication.